Kardigan Inc (KARD)

• Market cap: $1.35B
• 1 day: -0.9%
• 5 days: -13.78%
• 1 month: -30.28%
• 3 months: -34.68%
• 6 months: -34.59%
• Year to date: -34.59%
• 1 year: -34.59%
• 5 years: -34.59%
• 10 years: -34.59%
• Sector: Healthcare
• Industry: Biotechnology

About: Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.